-
Following the phenomenal success of the drug sildenafil (Viagra) in treating sexual dysfunction in men, pharmaceutical companies have recently focused intense interest and research funding toward finding a comparable drug that will offer the same benefits to women.
-
All pharmacists need to play an active role in the fight against antimicrobial resistance, says Michael Rybak, president of the Society of Infectious Diseases Pharmacists in Austin, TX, and professor of pharmacy and medicine at the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University in Detroit.
-
The following drugs are in various stages of clinical studies and trials.
-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA).
-
Pharmacists and other health care professionals must be aggressive in fighting against drug-resistant bacteria or face serious consequences, infectious disease control specialists say.
-
The Society of Infectious Diseases Pharmacists in Austin, TX, recently convened a panel with other health care organizations to discuss the recent increase in antibiotic-resistant infections.
-
The worldwide outbreak of severe acute respiratory syndrome (SARS) has put pharmacists and other health care professionals on alert. The incidence of SARS cases in the United States seems to be contained, but health officials warn that the threat is still real until Asia is able to control the virus.
-
The Centers for Disease Control and Prevention (CDC) has provided the following basic information about severe acute respiratory syndrome (SARS).
-
FDA adds heart benefit to simvastatin (Zocor) label; Pharmacists needed for underserved populations; APhA releases bulletin on gabapentin (Neurontin); Smallpox compensation bill becomes law; PhRMA plans to report counterfeit drugs to FDA
-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA):
